Ortoma AB Series B (ST:ORT-B) — Market Cap & Net Worth
Market Cap & Net Worth: Ortoma AB Series B (ORT-B)
Ortoma AB Series B (ST:ORT-B) has a market capitalization of $35.50 Million (Skr329.84 Million) as of August 28, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #23302 globally and #442 in its home market, demonstrating a -2.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ortoma AB Series B's stock price Skr7.70 by its total outstanding shares 42836477 (42.84 Million). Check today's stock price for Ortoma AB Series B for real-time trading data and today's change.
Ortoma AB Series B Market Cap History: 2025 to 2026
Ortoma AB Series B's market capitalization history from 2025 to 2026. Data shows growth from $62.92 Million to $35.50 Million (0.00% CAGR).
Index Memberships
Ortoma AB Series B is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.54 Billion | 0.23% | #78 of 281 |
Weight: Ortoma AB Series B's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Ortoma AB Series B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ortoma AB Series B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check net assets of Ortoma AB Series B to evaluate the company's book value and shareholders' equity.
Latest Price to Sales (P/S) Ratio
0.97x
Ortoma AB Series B's market cap is 0.97 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $62.92 Million | $64.64 Million | -$19.19 Million | 0.97x | N/A |
Competitor Companies of ORT-B by Market Capitalization
Companies near Ortoma AB Series B in the global market cap rankings as of August 28, 2026. Also see Ortoma AB Series B (ORT-B) cash conversion ratio for how efficiently the company converts equity into cash flow.
Key companies related to Ortoma AB Series B by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #198 globally with a market cap of $126.45 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #232 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #248 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $114.10 |
| #198 | Stryker Corporation | NYSE:SYK | $126.45 Billion | $329.67 |
| #232 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.02 |
| #248 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Ortoma AB Series B Historical Marketcap From 2025 to 2026
Between 2025 and today, Ortoma AB Series B's market cap moved from $62.92 Million to $ 35.50 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr35.50 Million | -43.59% |
| 2025 | Skr62.92 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 27th, 2026 the market cap of Ortoma AB Series B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.50 Million USD |
| MoneyControl | $35.50 Million USD |
| MarketWatch | $35.50 Million USD |
| marketcap.company | $35.50 Million USD |
| Reuters | $35.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ortoma AB Series B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more